These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27575657)

  • 1. A design space exploration for control of Critical Quality Attributes of mAb.
    Bhatia H; Read E; Agarabi C; Brorson K; Lute S; Yoon S
    Int J Pharm; 2016 Oct; 512(1):242-252. PubMed ID: 27575657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality by design for herbal drugs: a feedforward control strategy and an approach to define the acceptable ranges of critical quality attributes.
    Yan B; Li Y; Guo Z; Qu H
    Phytochem Anal; 2014; 25(1):59-65. PubMed ID: 24108478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QbD-guided pharmaceutical development of Pembrolizumab biosimilar candidate PSG-024 propelled to industry meeting primary requirements of comparability to Keytruda®.
    Jaffar-Aghaei M; Khanipour F; Maghsoudi A; Sarvestani R; Mohammadian M; Maleki M; Havasi F; Rahmani H; Karagah AH; Kazemali MR
    Eur J Pharm Sci; 2022 Jun; 173():106171. PubMed ID: 35378209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a design space and predictive statistical model for capsule filling of low-fill-weight inhalation products.
    Faulhammer E; Llusa M; Wahl PR; Paudel A; Lawrence S; Biserni S; Calzolari V; Khinast JG
    Drug Dev Ind Pharm; 2016; 42(2):221-30. PubMed ID: 26023991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated Application of Quality-by-Design Principles to Drug Product Development: A Case Study of Brivanib Alaninate Film-Coated Tablets.
    Badawy SI; Narang AS; LaMarche KR; Subramanian GA; Varia SA; Lin J; Stevens T; Shah PA
    J Pharm Sci; 2016 Jan; 105(1):168-81. PubMed ID: 26852852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of the manufacturing process of a complex amphotericin B liposomal formulation using quality by design approach.
    Liu H; Rivnay B; Avery K; Myung JH; Kozak D; Landrau N; Nivorozhkin A; Ashraf M; Yoon S
    Int J Pharm; 2020 Jul; 585():119473. PubMed ID: 32473373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of critical quality attributes for monoclonal antibodies using quality by design principles.
    Alt N; Zhang TY; Motchnik P; Taticek R; Quarmby V; Schlothauer T; Beck H; Emrich T; Harris RJ
    Biologicals; 2016 Sep; 44(5):291-305. PubMed ID: 27461239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-industry forum on benchmarking critical quality attribute identification and linkage to process characterization studies.
    Demmon S; Bhargava S; Ciolek D; Halley J; Jaya N; Joubert MK; Koepf E; Smith P; Trexler-Schmidt M; Tsai P
    Biologicals; 2020 Sep; 67():9-20. PubMed ID: 32665104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the quality by design approach to the drug substance manufacturing process of an Fc fusion protein: towards a global multi-step design space.
    Eon-duval A; Valax P; Solacroup T; Broly H; Gleixner R; Strat CL; Sutter J
    J Pharm Sci; 2012 Oct; 101(10):3604-18. PubMed ID: 22821774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. System-wide hybrid MPC-PID control of a continuous pharmaceutical tablet manufacturing process via direct compaction.
    Singh R; Ierapetritou M; Ramachandran R
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1164-82. PubMed ID: 23523542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing a control system using QbD principles.
    Kepert JF; Cromwell M; Engler N; Finkler C; Gellermann G; Gennaro L; Harris R; Iverson R; Kelley B; Krummen L; McKnight N; Motchnik P; Schnaible V; Taticek R
    Biologicals; 2016 Sep; 44(5):319-31. PubMed ID: 27430904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scientific and Regulatory Considerations in Solid Oral Modified Release Drug Product Development.
    Li M; Sander S; Duan J; Rosencrance S; Miksinski SP; Yu L; Seo P; Rege B
    AAPS J; 2016 Nov; 18(6):1406-1417. PubMed ID: 27650190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage 2 Process Performance Qualification (PPQ): a Scientific Approach to Determine the Number of PPQ Batches.
    Pazhayattil A; Alsmeyer D; Chen S; Hye M; Ingram M; Sanghvi P
    AAPS PharmSciTech; 2016 Aug; 17(4):829-33. PubMed ID: 26349690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of a stability-indicating method by Quality-by-Design versus Quality-by-Testing: a case of a learning process.
    Hubert C; Lebrun P; Houari S; Ziemons E; Rozet E; Hubert P
    J Pharm Biomed Anal; 2014 Jan; 88():401-9. PubMed ID: 24176744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioreactor process parameter screening utilizing a Plackett-Burman design for a model monoclonal antibody.
    Agarabi CD; Schiel JE; Lute SC; Chavez BK; Boyne MT; Brorson KA; Khan M; Read EK
    J Pharm Sci; 2015 Jun; 104(6):1919-1928. PubMed ID: 25762022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality by Design Approaches to Formulation Robustness-An Antibody Case Study.
    Wurth C; Demeule B; Mahler HC; Adler M
    J Pharm Sci; 2016 May; 105(5):1667-1675. PubMed ID: 27001536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality by design approach for optimizing the formulation and physical properties of extemporaneously prepared orodispersible films.
    Visser JC; Dohmen WM; Hinrichs WL; Breitkreutz J; Frijlink HW; Woerdenbag HJ
    Int J Pharm; 2015 May; 485(1-2):70-6. PubMed ID: 25746737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design space approach in the optimization of the spray-drying process.
    Lebrun P; Krier F; Mantanus J; Grohganz H; Yang M; Rozet E; Boulanger B; Evrard B; Rantanen J; Hubert P
    Eur J Pharm Biopharm; 2012 Jan; 80(1):226-34. PubMed ID: 21983606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A PAT-based qualification of pharmaceutical excipients produced by batch or continuous processing.
    Hertrampf A; Müller H; Menezes JC; Herdling T
    J Pharm Biomed Anal; 2015 Oct; 114():208-15. PubMed ID: 26072012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QbD implementation and Post Approval Lifecycle Management (PALM).
    Ohage E; Iverson R; Krummen L; Taticek R; Vega M
    Biologicals; 2016 Sep; 44(5):332-40. PubMed ID: 27449920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.